1.
Interv Med Appl Sci
; 6(4): 178-82, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25598992
RESUMO
First generation drug-eluting stent can cause a paradoxical "in-segment" coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-eluting stents (EES).